iRhythm Holdings, Inc. IRTC
7 trading plans running, 6 Form 144 notices for $1.9M
10-Q, 10-K and Form 144What IRTC's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From May 5, 2025 to May 12, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Julie Rodda(2) EVP, Chief People & Capability Officer |
Adopted 10b5-1 plan | Dec 9, 2025 | 10-Q Apr 30, 2026 | ||
| Brian Yoor Director |
Adopted 10b5-1 plan | Dec 3, 2025 | 10-K Feb 19, 2026 | ||
| Chad Patterson Chief Commercial and Product Officer |
Adopted 10b5-1 plan | Dec 3, 2025 | 10-K Feb 19, 2026 | ||
| Marc Rosenbaum SVP, Chief Accounting Officer |
Adopted 10b5-1 plan | Nov 25, 2025 | 10-K Feb 19, 2026 | ||
| Mervin Smith Executive Vice President, Business Operations |
Adopted 10b5-1 plan | Nov 19, 2025 | 10-K Feb 19, 2026 | ||
| Bruce Bodaken Director |
Adopted 10b5-1 plan | Nov 17, 2025 | 10-K Feb 19, 2026 | ||
| Sumi Shrishrimal Executive Vice President, Chief Risk Officer |
Adopted 10b5-1 plan | May 23, 2025 | 10-Q Jul 31, 2025 | ||
| Abhijit Talwalkar Director |
Adopted 10b5-1 plan | May 12, 2025 | 10-Q Jul 31, 2025 | ||
| Marc Rosenbaum Senior Vice President, Chief Accounting Officer |
Adopted 10b5-1 plan | May 12, 2025 | 10-Q Jul 31, 2025 | ||
| Mark Rubash Director(2) |
Adopted 10b5-1 plan | May 5, 2025 | 10-Q Jul 31, 2025 | ||
| Quentin Blackford President and Chief Executive Officer |
Adopted 10b5-1 plan | May 5, 2025 | 10-Q Jul 31, 2025 | ||
| Chad Patterson Chief Commercial Officer |
Adopted 10b5-1 plan | Nov 25, 2024 | 10-K Feb 20, 2025 | ||
What the company wroteOn November 25, 2024, Chad Patterson, the Company's Chief Commercial Officer, entered into a prearranged written stock sale plan in accordance with Rule 10b5-1 (the “Patterson 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company's common stock. The Patterson 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Patterson 10b5-1 Plan provides for the potential sale of up to 7,951 shares of the Company's common stock, including upon the vesting and settlement of restricted stock units and performance restricted stock units for shares of the Company's common stock, so long as the market price of the Company's common stock is higher than a certain minimum threshold prices specified in Patterson 10b5-1 Plan, between February 24, 2025 and December 2, 2025. | |||||
| Daniel Wilson Chief Financial Officer |
Adopted 10b5-1 plan | Nov 14, 2024 | 10-K Feb 20, 2025 | ||
What the company wroteOn November 14, 2024, Daniel Wilson, the Company's Chief Financial Officer, entered into a prearranged written stock sale plan in accordance with Rule 10b5-1 (the “Wilson 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company's common stock. The Wilson 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Wilson 10b5-1 Plan provides for the potential sale of up to 18,000 shares of the Company's common stock, including upon the vesting and settlement of restricted stock units and performance restricted stock units for shares of the Company's common stock, so long as the market price of the Company's common stock is higher than a certain minimum threshold prices specified in Wilson 10b5-1 Plan, between March 3, 2025 and August 11, 2025. | |||||
| Mark J. Day Chief Technology Officer |
Adopted 10b5-1 plan | Mar 13, 2024 | 10-Q May 2, 2024 | ||
What the company wroteOn March 13, 2024, Mark J. Day, the Company's then Chief Technology Officer, entered into a prearranged written stock sale plan in accordance with Rule 10b5-1 (the “Day Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s common stock. The Day Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Day Rule 10b5-1 Plan provides for the potential sale of up to 6,090 shares of the Company’s common stock, including upon the vesting and settlement of restricted stock units and performance restricted stock units for shares of the Company’s common stock, so long as the market price of the Company’s common stock is higher than certain minimum threshold prices specified in the Day Rule 10b5-1 Plan, between June 12, 2024 and March 13, 2025. The Day Rule 10b5-1 Plan includes a representation from Mr. Day to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Day Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Day Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Day Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which the insider was unaware, or with respect to any material nonpublic information acquired by the insider or the Company after the date of the representation. | |||||
| Dan Wilson, Company's Executive Vice President of Corporate Development and Investor Relations |
Adopted 10b5-1 plan | May 31, 2023 | 10-Q Aug 4, 2023 | ||
What the company wroteOn May 31, 2023, Dan Wilson, the Company's Executive Vice President of Corporate Development and Investor Relations, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Wilson Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s common stock. The Wilson Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Wilson Rule 10b5-1 Plan provides for the potential sale of up to 20,706 shares of the Company’s common stock, including upon the vesting and settlement of restricted stock units and performance restricted stock units for shares of the Company’s common stock, so long as the market price of the Company’s common stock is higher than certain minimum threshold prices specified in the Wilson Rule 10b5-1 Plan, between August 22, 2023 and August 15, 2024.The Wilson Rule 10b5-1 Plan includes a representation from Mr. Wilson to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Wilson Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Wilson Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which the insider was unaware, or with respect to any material nonpublic information acquired by the insider or the Company after the date of the representation. | |||||
| Bruce Bodaken Director |
Adopted plan | – | 10-Q Apr 30, 2026 | ||
Show the other 8 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| May 11, 2026 | ABHIJIT Y TALWALKAR Director |
5,312 | $626K |
| Mar 16, 2026 | MERVIN SMITH Officer |
2,585 | $295K |
| Feb 24, 2026 | MERVIN SMITH Officer |
732 | $103K |
| Feb 24, 2026 | MARC ROSENBAUM Officer |
280 | $39K |
| Feb 23, 2026 | ABHIJIT Y TALWALKAR Director |
5,312 | $774K |
| Dec 2, 2025 | CHAD PATTERSON Officer |
280 | $52K |
From the Form 144 XML filed with the SEC, since Dec 2, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IRTC/export.csv") into a cell.